An Open-Label, Single-Centre, Phase I Study to Assess the Excretion, Metabolism and Plasma Pharmacokinetics Following a Single Oral Dose of 60 mg [14C]AZD9668 in Healthy Male Volunteers.

Trial Profile

An Open-Label, Single-Centre, Phase I Study to Assess the Excretion, Metabolism and Plasma Pharmacokinetics Following a Single Oral Dose of 60 mg [14C]AZD9668 in Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2010

At a glance

  • Drugs Alvelestat (Primary)
  • Indications Bronchiectasis; Chronic obstructive pulmonary disease
  • Focus Pharmacokinetics
  • Most Recent Events

    • 02 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top